Company Management

Xinnate

Pharmaceutical Manufacturing Lund, Skåne Län, Se 9 employees

Employees: 9
Contacts: 2
Emails: 2

xinnate.com LinkedIn

Xinnate Overview

Headquarters: Lund, Skåne Län, Se
Website: xinnate.com
Industry: Pharmaceutical Manufacturing
Employees: 9
Founded: 2019
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

that ease the daily burdens of EB

About Xinnate

Xinnate is a pharmaceutical development company in Lund, Sweden developing novel, pharmaceutical therapies based on a pioneering technology of immune modulating peptides, that targets dysfunctional healing by controlling presence of microbials and the complex interplay of inflammatory responses. Xinnate runs an ambitious research and clinical program for TCP25 including a clinical study in phase 1b in patients with Epidermolysis bullosa (EB). Late-stage clinical development and commercialization will take place in partnership with one or more leading pharmaceutical companies.

Xinnate Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage

Xinnate Org Chart

Sample employees and titles

Name	Title	Location	Contact
Kristian Ford	Partner at Advokatfirman Vinge	Greater Malmö Metropolitan Area, Sweden	Email
Michele Tavecchio	Senior Scientist at Xinnate/lund University		View
Matilda Hugerth	Head of Clinical Development, Xinnate	Sweden	View
Helene Hartman	CEO Xinnate Ab 📕	Kalmar County, Sweden	Email